ZA859892B - - Google Patents

Info

Publication number
ZA859892B
ZA859892B ZA859892A ZA859892A ZA859892B ZA 859892 B ZA859892 B ZA 859892B ZA 859892 A ZA859892 A ZA 859892A ZA 859892 A ZA859892 A ZA 859892A ZA 859892 B ZA859892 B ZA 859892B
Authority
ZA
South Africa
Application number
ZA859892A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU51577/85A priority Critical patent/AU581486B2/en
Priority to EP85309500A priority patent/EP0226679B1/en
Priority to JP60292357A priority patent/JPS62153219A/ja
Application filed filed Critical
Priority to ZA859892A priority patent/ZA859892B/xx
Publication of ZA859892B publication Critical patent/ZA859892B/xx
Priority to HK85294A priority patent/HK85294A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA859892A 1985-12-30 1985-12-30 ZA859892B (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU51577/85A AU581486B2 (en) 1985-12-30 1985-12-23 Graduated estrogen contraceptive
EP85309500A EP0226679B1 (en) 1985-12-30 1985-12-24 Contraceptive method and kit
JP60292357A JPS62153219A (ja) 1985-12-30 1985-12-26 避妊方法およびキツト
ZA859892A ZA859892B (ja) 1985-12-30 1985-12-30
HK85294A HK85294A (en) 1985-12-30 1994-08-18 Contraceptive method and kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA859892A ZA859892B (ja) 1985-12-30 1985-12-30

Publications (1)

Publication Number Publication Date
ZA859892B true ZA859892B (ja) 1986-07-08

Family

ID=25578197

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859892A ZA859892B (ja) 1985-12-30 1985-12-30

Country Status (5)

Country Link
EP (1) EP0226679B1 (ja)
JP (1) JPS62153219A (ja)
AU (1) AU581486B2 (ja)
HK (1) HK85294A (ja)
ZA (1) ZA859892B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071577B2 (en) 2004-04-20 2011-12-06 Bayer Pharma Aktiengesellschaft Multi-phase contraceptive preparation based on a natural estrogen
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
US8349820B2 (en) 2006-10-20 2013-01-08 Bayer Pharma Aktiengesellschaft Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226316A (en) * 1987-09-24 1991-10-25 Jencap Research Ltd Pharmaceutical contraceptive preparations and packages containing from 20-35 unit dosages comprising an estrogen and a progestin; the unit dosages having alternating estrogen and progestin dominance
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
WO2006014476A1 (en) * 2004-07-07 2006-02-09 Wyeth Cyclic progestin regimens and kits

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2431704A1 (de) * 1974-07-02 1976-01-22 Asche Ag Stufenkombinationspraeparate per kontrazeption
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071577B2 (en) 2004-04-20 2011-12-06 Bayer Pharma Aktiengesellschaft Multi-phase contraceptive preparation based on a natural estrogen
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
US8349820B2 (en) 2006-10-20 2013-01-08 Bayer Pharma Aktiengesellschaft Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido

Also Published As

Publication number Publication date
HK85294A (en) 1994-08-26
AU581486B2 (en) 1989-02-23
EP0226679B1 (en) 1991-08-28
JPS62153219A (ja) 1987-07-08
EP0226679A1 (en) 1987-07-01
AU5157785A (en) 1987-06-25

Similar Documents

Publication Publication Date Title
IN163477B (ja)
AU549439B2 (ja)
AU3954685A (ja)
AU4121285A (ja)
AU4708385A (ja)
BA96126A (ja)
GR850982B (ja)
BG44671A1 (ja)
BG44841A1 (ja)
BE901481A (ja)
BE901679A (ja)
BE902936A (ja)
BE905108A (ja)
BG39572A1 (ja)
BG40852A1 (ja)
BG44563A1 (ja)
BG44571A1 (ja)
BG44572A1 (ja)
BG44581A1 (ja)
BG44643A1 (ja)
BG44654A1 (ja)
BG44657A1 (ja)
BG44660A1 (ja)
BG44667A1 (ja)
CN85300239S (ja)